Nephrology Drugs Market Predicts to Generate $23.40 Billion

PORTLAND, Oregon, Jan. 13, 2022 (GLOBE NEWSWIRE) – According to the report published by Allied Market Research, Kidney disease drug market Generated $14.50 billion in 2020, expected to generate $23.40 billion by 2030, experiencing a CAGR of 5.0% from 2021 to 2030. The report provides a detailed analysis of changing market trends, top sectors, key investment pockets, value chain, The regional landscape, and the competitive scenario.

The rising incidence of chronic kidney disease and technological advancement in developing countries is driving the growth of the global kidney disease drug market. However, the high cost of treatment and lack of awareness regarding Chronic Kidney Diseases limits the growth of the market. On the other hand, supportive initiatives by governments for regulatory approvals create new opportunities in the coming years.

Download Report Form

Impact of Covid-19 on the kidney disease drug market-

  • The Covid-19 pandemic has delayed clinical trials of kidney disease drugs and led to a decrease in the use of these drugs. Due to the worldwide lockdown, production activities have stopped. Moreover, disruptions to the supply chain have also occurred.
  • The epidemic has become a major disincentive for drug trials for kidney disease. It has halted clinical research worldwide and affected the management of ongoing trials and the planning of future trials.
  • However, market players and research institutes have started clinical trials related to Covid-19 to understand the effects of chronic kidney disease drugs on patients suffering from Covid-19 infection.

Get detailed analysis of the impact of COVID-19 on Kidney Disease Drugs market-

The report provides detailed segmentation of the global Kidney Disease Drugs market based on drug category, management route, distribution channel, and region.

Based on the drug category, the ACE inhibitor segment contributed the highest share in 2020, accounting for more than two-fifths of the total share, and is expected to continue its leadership position during the forecast period. Furthermore, this segment is expected to show the highest compound annual growth rate of 5.6% from 2021 to 2030. The report also analyzes segments including calcium channel blockers, beta blockers, diuretics, and others.

Based on distribution channel, the retail pharmacy segment captured the largest share in 2020, contributing nearly two-fifths of the total share of the global nephrology drug market, and is expected to maintain its dominant share during the forecast period. However, the online pharmacy segment is estimated to experience the largest compound annual growth rate of 6.9% from 2021 to 2030.

To inquire about a purchase-

Based on region, North America contributed the highest share in 2020, accounting for about two-fifths of the total share, and is expected to maintain its leading position in terms of revenue by 2030. However, the Asia Pacific region is estimated to project the fastest compound annual growth rate (CAGR). by 7.7% during the forecast period. Other counties covered by the report include Europe and LAMEA.

The list of companies analyzed in the research on the global nephrology drug market includes AstraZeneca, Akebia Therapeutics, Inc. and AbbVie Inc. and F. Hoffmann-La Roche and Amgen Inc. and GlaxoSmithkline PLC. and FibroGen Inc. and Pfizer Inc. Johnson & Johnson and Teva Pharmaceutical Industries Ltd.

Official press release-

AVENUE- Subscription-Based Library (Premium On Demand, Subscription-Based Pricing Model) Provided by Allied Market Research:

AMR offers Library Avenue subscription-based online, which is specifically designed to provide cost-effective, one-stop solutions to organizations, investors, and universities. With Avenue, subscribers can benefit from a complete repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can access online quantitative and qualitative data in PDF and Excel formats along with analyst support, customization and updated versions of reports.

Get access to your report library anytime, from any device, from anywhere. For more details follow the link:

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business consulting firm of Allied Analytics LLP headquartered in Portland, Oregon. Allied Market Research provides global organizations as well as medium and small businesses with unparalleled quality of Market Research Reports and Business Intelligence Solutions. AMR has a targeted viewpoint to provide business insights and consultancy to help its clients make strategic business decisions and achieve sustainable growth in their respective market areas. AMR provides its services across 11 industry sectors including Life scienceconsumer goods, materials, chemicals, construction, manufacturing, food and beverage, energy, energy, semiconductors, electronics, automotive, transportation, information and communications technology, media, aerospace and defense, and BFSI.

We are in professional institutional relationships with many companies and this helps us extract market data that helps us in creating accurate research spreadsheets and assures the utmost accuracy in our market forecasts. CEO of Allied Market Research Pawan Kumar It plays an essential role in inspiring and encouraging everyone associated with the company to maintain high data quality and help customers in every way possible to achieve success. All the data presented in the reports published by us are extracted through preliminary interviews with senior officials from the leading companies in the respective field. Our secondary data acquisition methodology includes in-depth online and offline research and discussions with industry knowledgeable professionals and analysts.

David Correa

5933 NE Win Sivers Drive
#205, Portland, or 97220
United States of America
Toll Free: +1-800-792-5285
United Kingdom: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
[email protected]
Follow us: LinkedIn Twitter


Leave a Comment